Evaluating The Frequency of Autoantibodies in Patients with Chronic Hepatitis B
Journal Title: Viral Hepatitis Journal - Year 2020, Vol 26, Issue 1
Abstract
Objectives: The objective of this study is to evaluate the frequency of autoantibodies retrospectively in newly diagnosed chronic hepatitis B (CHB) patients. Materials and Methods: The study was retrospectively conducted in between Jan 2010 and August 2015 in a research and training hospital in İstanbul with 122 patients (ages of 17-80) consulted to Gastroenterology and Infection Diseases and diagnosed with CHB and 117 healthy control group. In both groups, positive and negative rates of anti-nuclear antibody (ANA), anti-smooth muscle antibody (ASMA), anti-mitochondrial antibody (AMA) and anti-liver-kidney mitochondrial antibody (anti-LKM) were compared. Results: No AMA and LKM1 were observed in any patient or control groups. ANA result was positive in 9.8% of the patient group and 8.5% of the control group; and there was no statistically significant difference between them (p>0.05). ASMA result was positive in 5.7% of the patient group and 0.9% of the control group; and the difference between them was very close to significance but statistically not enough to be significant (p>0.05). Hepatosteatosis level of the patient group was significantly lower than the control group, statistically (p<0.05). Conclusion: In this study, it is concluded that the low frequency of autoantibody may depend on the fact that it was only examined in CHB patients who are not receiving any treatment. Examination of autoantibodies in newly diagnosed chronic hepatitis B patients before and after treatment may provide insight in terms of occuring autoimmune phenomena cases and extrahepatic findings.
Authors and Affiliations
Umut Aykanat, Fatma Ekşi Polat, Elif Yorulmaz, Hatice Yorulmaz, Münevver Gül Avşar, Mehmet Öncü, Ayşe Banu Esen, Ümit Seza Tetikkurt
Keywords
Related Articles
- EP ID EP684575
- DOI 10.4274/vhd.galenos.2020.2019.0035
- Views 129
- Downloads 0
Occult Hepatitis B in Hemodialysis Patients
Objectives: We aimed to detect occult hepatitis B (OHB) in hemodialysis patients at a higher-risk for OHB. Materials and Methods: The study included 567 patients with chronic renal failure aged 18 years and older who un...
The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience
Objectives: Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir (PrOD) seems to be highly effective and safe in chronic haemodialysis (CHD) patients. We presented our experiences of treatment with PrOD in CHD patients. Material...
Frequency of Hepatitis Delta Virus in Hepatitis B Surfaceantigen-positive Patients
Objectives: The prevalence of hepatitis delta virus (HDV) worldwide shows geographical differences. Although there are several studies on anti-HDV seroprevalence rates in hepatitis B surface antigen (HBsAg)-positive pati...
An Evaluation of Health Personnel Exposed to Occupational Injuries in Terms of HBV, HCV, and HIV Infections
Objectives: This study aims to determine the rates, distribution and risk factors of needle-stick and sharps injuries that cause diseases spread through blood and body fluids, to discuss relevant precautions, and to moni...
Genotyping Distribution of Hepatitis C Virus in Şanlıurfa Province and Effect of Syrian Patients
Objectives: Hepatitis C virus (HCV) is one of the major causes of global mortality and morbidity. The purpose of our study was to characterize the distribution of HCV genotypes in Şanlıurfa, to see the effect of patients...